Nrgene Technologies Ltd Net Assets
Nrgene Technologies Ltd net assets. Based on the latest financial reports, Nrgene Technologies Ltd (NRGN) has net assets worth ILA4.42 Million ILA (≈ $11.85K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA9.54 Million ≈ $25.59K USD) and total liabilities (ILA5.12 Million ≈ $13.74K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Nrgene Technologies Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA4.42 Million |
| % of Total Assets | 46.3% |
| Annual Growth Rate | N/A |
| 5-Year Change | -75.01% |
| 10-Year Change | N/A |
| Growth Volatility | 21.85 |
Net Assets of Nrgene Technologies Ltd (2018–2025)
Net assets of Nrgene Technologies Ltd from 2018 to 2025. This chart illustrates how Nrgene Technologies Ltd's net assets have evolved over time, based on quarterly financial data. See Nrgene Technologies Ltd net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Nrgene Technologies Ltd (2018–2025)
The table below shows the annual net assets of Nrgene Technologies Ltd from 2018 to 2025. For live market cap and overall valuation, see Nrgene Technologies Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA4.42 Million ≈ $11.85K |
+10.31% |
| 2024-12-31 | ILA4.01 Million ≈ $10.74K |
-44.47% |
| 2023-12-31 | ILA7.21 Million ≈ $19.34K |
-41.15% |
| 2022-12-31 | ILA12.26 Million ≈ $32.87K |
-30.67% |
| 2021-12-31 | ILA17.68 Million ≈ $47.40K |
+419.90% |
| 2020-12-31 | ILA-5.53 Million ≈ $-14.82K |
-48.34% |
| 2019-12-31 | ILA-3.73 Million ≈ $-9.99K |
-180.78% |
| 2018-12-31 | ILA-1.33 Million ≈ $-3.56K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Nrgene Technologies Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3170600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Nrgene Technologies Ltd Net Assets Breakdown (December 2025)
Nrgene Technologies Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA39.00K | 0.90% |
| Other Components | ILA59.13 Million | 1371.54% |
| Total Equity | ILA4.31 Million | 100.00% |
Nrgene Technologies Ltd Competitors by Market Cap
The table below lists competitors of Nrgene Technologies Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Williamson Magor & Company Limited
NSE:WILLAMAGOR
|
$2.47 Million |
|
CL8 Holdings Ltd
AU:CL8
|
$2.47 Million |
|
Locafy Ltd
NASDAQ:LCFY
|
$2.47 Million |
|
John Wood Group PLC
LSE:WG
|
$2.47 Million |
|
Alpha Star Acquisition Corp
NASDAQ:ALSA
|
$2.46 Million |
|
Imagine Lithium Inc
V:ILI
|
$2.46 Million |
|
NuGen Medical Devices Inc
V:NGMD
|
$2.46 Million |
|
Global Power Solutions Corp.
V:PWER
|
$2.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nrgene Technologies Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,962,000 to 4,311,000, a change of 349,000 (8.8%).
- Net loss of 1,502,000 reduced equity.
- New share issuances of 1,622,000 increased equity.
- Other comprehensive income decreased equity by 6,289,000.
- Other factors increased equity by 6,518,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-1.50 Million | -34.84% |
| Share Issuances | ILA1.62 Million | +37.62% |
| Other Comprehensive Income | ILA-6.29 Million | -145.88% |
| Other Changes | ILA6.52 Million | +151.19% |
| Total Change | ILA- | 8.81% |
Book Value vs Market Value Analysis
This analysis compares Nrgene Technologies Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 210.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | ILA-0.15 | ILA69.30 | x |
| 2019-12-31 | ILA-0.43 | ILA69.30 | x |
| 2020-12-31 | ILA-0.63 | ILA69.30 | x |
| 2021-12-31 | ILA1.46 | ILA69.30 | x |
| 2022-12-31 | ILA0.98 | ILA69.30 | x |
| 2023-12-31 | ILA0.57 | ILA69.30 | x |
| 2024-12-31 | ILA0.32 | ILA69.30 | x |
| 2025-12-31 | ILA0.33 | ILA69.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nrgene Technologies Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -34.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -47.38%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 2.21x
- Recent ROE (-34.84%) is above the historical average (-36.26%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -61.45% | 1.56x | 0.00x | ILA-4.36 Million |
| 2019 | 0.00% | -51.41% | 1.81x | 0.00x | ILA-3.54 Million |
| 2020 | 0.00% | -44.72% | 1.85x | 0.00x | ILA-2.59 Million |
| 2021 | -47.16% | -186.83% | 0.17x | 1.49x | ILA-10.11 Million |
| 2022 | -50.63% | -196.49% | 0.18x | 1.41x | ILA-7.43 Million |
| 2023 | -72.68% | -262.02% | 0.19x | 1.50x | ILA-5.96 Million |
| 2024 | -84.78% | -260.39% | 0.21x | 1.51x | ILA-3.76 Million |
| 2025 | -34.84% | -47.38% | 0.33x | 2.21x | ILA-1.93 Million |
Industry Comparison
This section compares Nrgene Technologies Ltd's net assets metrics with peer companies in the Software - Application industry.
Industry Context
- Industry: Software - Application
- Average net assets among peers: $185,956,874
- Average return on equity (ROE) among peers: 10.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nrgene Technologies Ltd (NRGN) | ILA4.42 Million | 0.00% | 1.16x | $2.47 Million |
| Abra Information Technologies (ABRA) | $122.50 Million | -1.90% | 0.12x | $103.84 Million |
| Idomoo Ltd (IDMO) | $-8.20 Million | 0.00% | 0.00x | $22.32 Million |
| Nice Ltd (NICE) | $569.57 Million | 3.93% | 0.38x | $5.23 Billion |
| One Software Technologies Ltd (ONE) | $326.75 Million | 25.22% | 2.16x | $1.40 Billion |
| Photomyne Ltd (PHTM) | $12.88 Million | 19.43% | 0.38x | $10.29 Million |
| Sarine Technologies Ltd (SARN) | $21.69 Million | 43.10% | 0.36x | $27.92 Million |
| Synel M.L.L Payway Ltd (SNEL) | $146.08 Million | 3.53% | 1.37x | $26.40 Million |
| Sapiens International Corporation NV (SPNS) | $479.63 Million | 15.05% | 0.44x | $2.09 Billion |
| Tectona (TECT) | $2.70 Million | -11.51% | 0.30x | $9.25 Million |
About Nrgene Technologies Ltd
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing ge… Read more